import serviceImage from '@/assets/ade_pde_oel_oeb_reports.png';
const link = '/services/ade-pde-oel/tra-reports';

export default {
  slug: 'tra-reports',
  parentSlug: 'ade-pde-oel',
  service_id: 'tra_prep_001',
  report_type: 'Comprehensive Toxicological Risk Assessment',
  title: 'Toxicological Risk Assessment (TRA) Report Services',
  name: 'TRA & HBEL Documentation',
  description:
    'Regulatory-grade TRA reports with HBEL determination, cleaning validation support, and cross-contamination control strategies for global compliance.',
  full_description:
    'Our Toxicological Risk Assessment service delivers scientifically rigorous and inspection-ready documentation for pharmaceutical manufacturers. We prepare comprehensive TRA reports including compound-specific monographs, HBEL/PDE calculations, cleaning validation justifications, and cross-contamination control strategies. Each assessment undergoes dual review by certified toxicologists and includes regulatory alignment statements for EMA, FDA, WHO, and PIC/S requirements.',
  estimated_duration: '5-7 business days (expedited options available)',
  deliverables: [
    'Comprehensive TRA report with executive summary',
    'Detailed toxicological monograph (NOAEL/LOAEL/LD50 data)',
    'HBEL/PDE calculation with uncertainty factor justification',
    'Cleaning validation limit rationale (MACO, swab/rinse limits)',
    'Cross-contamination risk assessment matrix',
    'Product Quality Review (PQR) support documentation',
    'Regulatory compliance gap analysis',
    'Inspection-ready presentation package',
    'Training materials for quality teams',
  ],
  regulatory_basis: [
    'EMA Guideline on Setting Health-Based Exposure Limits (EMA/CHMP/CVMP/SWP/169430/2012)',
    'FDA Guidance for Industry: Cleaning Validation Requirements (2015)',
    'ICH Q3D Guideline for Elemental Impurities (R2)',
    'PIC/S PI 006-3 Recommendations on Cleaning Validation',
    'WHO TRS 1019 Annex 3: GMP for HVAC systems',
    'EU GMP Annex 15: Qualification and Validation',
    'ISO 10993-17: Biological Evaluation of Medical Devices',
  ],
  requires_data_from_client: true,
  target_industry: [
    'Pharmaceutical Manufacturing',
    'Biologics & Biosimilar Production',
    'Contract Development & Manufacturing (CDMO)',
    'API & Formulation Facilities',
    'Medical Device/Drug Combinations',
    'Veterinary Pharmaceutical Manufacturers',
  ],
  expertise_area: [
    'Regulatory Toxicology',
    'Risk Assessment Methodology',
    'Cleaning Validation Science',
    'GMP Documentation',
    'Cross-Contamination Control',
    'Quality Systems Support',
  ],
  is_active: true,
  pageLink: link,
  icon: '📄',
  image: {
    path: serviceImage,
    alt: 'Professional Toxicological Risk Assessment (TRA) report preparation services',
    caption: 'Scientifically validated TRA reports with regulatory compliance assurance.',
  },
  pageContent: {
    hero: {
      heading: 'Expert TRA & HBEL Documentation Services',
      tagline: 'Ensuring Safety and Compliance with Rigorous Toxicological Assessments',
      detail:
        'At Indivirtus Healthcare Services, we deliver inspection-ready Toxicological Risk Assessment (TRA) and Health-Based Exposure Limit (HBEL) documentation to support pharmaceutical manufacturers in achieving regulatory compliance and product safety.',
    },
    overview: {
      heading: 'Overview',
      overviewCards: [
        {
          heading: 'What We Do',
          detail:
            'We provide comprehensive TRA reports with HBEL/PDE calculations, cleaning validation justifications, and cross-contamination control strategies to ensure safe pharmaceutical manufacturing.',
        },
        {
          heading: 'Why It Matters',
          detail:
            'TRA and HBEL documentation ensures product safety, prevents contamination, and meets stringent regulatory requirements, protecting patients and supporting market approval.',
        },
        {
          heading: 'Our Role',
          detail:
            'As a trusted CRO, we deliver scientifically robust, inspection-ready documentation to streamline compliance and support quality assurance in pharmaceutical manufacturing.',
        },
      ],
    },
    approach: {
      heading: 'Our Expert Approach',
      detail: [
        'At Indivirtus, our TRA and HBEL documentation services are led by certified toxicologists who conduct rigorous assessments, including detailed monographs and uncertainty factor justifications. Each report undergoes a dual review process to ensure scientific accuracy and regulatory alignment. Our tailored solutions support cleaning validation, cross-contamination control, and product quality reviews, delivering compliance with global standards.',
      ],
    },
    deliverables: {
      heading: 'Service Deliverables',
      itemList: [
        'Comprehensive TRA report with executive summary',
        'Detailed toxicological monograph (NOAEL/LOAEL/LD50 data)',
        'HBEL/PDE calculation with uncertainty factor justification',
        'Cleaning validation limit rationale (MACO, swab/rinse limits)',
        'Cross-contamination risk assessment matrix',
        'Product Quality Review (PQR) support documentation',
        'Regulatory compliance gap analysis',
        'Inspection-ready presentation package',
        'Training materials for quality teams',
      ],
    },
    compliance: {
      heading: 'Regulatory Compliance & Guidelines',
      detail: [
        'Our TRA and HBEL documentation services adhere to stringent global regulatory standards, ensuring your manufacturing processes are audit-ready and compliant. By aligning with leading guidelines, we provide robust, inspection-ready documentation to support seamless market access.',
      ],
      itemList: [
        'EMA Guideline on Setting Health-Based Exposure Limits (EMA/CHMP/CVMP/SWP/169430/2012)',
        'FDA Guidance for Industry: Cleaning Validation Requirements (2015)',
        'ICH Q3D Guideline for Elemental Impurities (R2)',
        'PIC/S PI 006-3 Recommendations on Cleaning Validation',
        'WHO TRS 1019 Annex 3: GMP for HVAC systems',
        'EU GMP Annex 15: Qualification and Validation',
        'ISO 10993-17: Biological Evaluation of Medical Devices',
      ],
    },
    applications: {
      heading: 'Applications & Use Cases',
      detail: [
        'Our TRA and HBEL documentation services are essential for manufacturers developing new products, validating cleaning processes, or ensuring compliance in shared facilities. These solutions support regulatory submissions, product quality reviews, and contamination control strategies.',
        "Whether you're scaling production or addressing regulatory audits, our comprehensive documentation provides the scientific foundation for success.",
      ],
    },
    conclusion: {
      heading: 'Why Choose Indivirtus',
      detail: [
        'Indivirtus Healthcare Services is a trusted partner for pharmaceutical manufacturers, delivering inspection-ready TRA and HBEL documentation. Our certified toxicologists and regulatory experts ensure scientific rigor, rapid turnaround, and strict confidentiality. With adherence to industry best practices, we provide robust solutions that support compliance and quality assurance.',
        'Choose Indivirtus for reliable, scientifically defensible documentation that drives regulatory success.',
      ],
    },
    cta: {
      heading: 'Ready for Inspection-Ready TRA Documentation?',
      tagline: 'Partner with Indivirtus for robust, compliant toxicological assessments.',
      aria: 'Contact Indivirtus for TRA and HBEL Documentation Services',
    },
  },
  gtm: {
    eventCategory: 'Regulatory Services',
    eventAction: 'Service Inquiry',
    eventLabel: 'TRA Report Preparation',
    customDimensions: {
      serviceTier: 'Expert',
      regulatoryLevel: 'EMA/FDA/WHO',
    },
    dataLayerPush: {
      reportType: ['TRA Report', 'HBEL Documentation'],
      methodology: ['ICH Q3D', 'PDE Calculation'],
      complianceFramework: ['GMP Annex 15', 'PIC/S'],
    },
  },
  schema: {
    '@context': 'https://schema.org',
    '@type': 'ProfessionalService',
    name: 'Toxicological Risk Assessment Services',
    description: 'Complete TRA report preparation with HBEL determination and regulatory compliance support.',
    serviceType: ['Risk Assessment', 'Regulatory Compliance', 'Quality Assurance'],
    provider: {
      '@type': 'Organization',
      name: 'Indivirtus',
      url: 'https://www.indivirtus.com',
      logo: 'https://www.indivirtus.com/logo.png',
      sameAs: [
        'https://www.linkedin.com/company/indivirtus-group-of-companies',
        'https://twitter.com/indivirtus',
        'https://www.facebook.com/Indivirtus',
        'https://www.instagram.com/indivirtus_healthcare',
      ],
    },
    areaServed: {
      '@type': 'Country',
      name: 'Global',
    },
    availableChannel: {
      '@type': 'ServiceChannel',
      serviceUrl: link,
      servicePhone: '+91-9131925456',
      servicePostalAddress: {
        '@type': 'PostalAddress',
        streetAddress: '522, Taj Plaza, TDI city, Sector 118',
        addressLocality: 'Mohali',
        addressRegion: 'Punjab',
        postalCode: '160059',
        addressCountry: 'India',
      },
      availableLanguage: ['English', 'German', 'French', 'Spanish'],
    },
    hasOfferCatalog: {
      '@type': 'OfferCatalog',
      name: 'TRA Report Services',
      itemListElement: [
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Comprehensive TRA Report',
            description: 'End-to-end toxicological risk assessment with HBEL determination.',
            serviceOutput: 'TRA Documentation Package',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Cleaning Validation Support',
            description: 'Scientifically justified cleaning limits with MACO calculations.',
            serviceOutput: 'Cleaning Validation Dossier',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'PQR Documentation Package',
            description: 'Audit-ready toxicology data for Product Quality Reviews.',
            serviceOutput: 'PQR Support Documentation',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Cross-Contamination Strategy',
            description: 'Risk-based control measures for multi-product facilities.',
            serviceOutput: 'Contamination Control Plan',
          },
        },
      ],
    },
    offers: {
      '@type': 'Offer',
      priceCurrency: ['INR', 'USD', 'EUR'],
      price: 'From ₹45,000 per compound (volume discounts available)',
      url: link,
      availability: 'https://schema.org/InStock',
      businessFunction: 'https://schema.org/ProvideService',
      eligibleCustomerType: 'https://schema.org/Business',
    },
  },
  faqSchema: {
    '@context': 'https://schema.org',
    '@type': 'FAQPage',
    mainEntity: [
      {
        '@type': 'Question',
        name: 'What scientific data do you require to prepare a TRA report?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We require complete toxicological data including: 1) Acute and chronic toxicity studies, 2) Genotoxicity/carcinogenicity data, 3) Reproductive toxicity findings, 4) Clinical human exposure data, 5) Pharmacological properties, and 6) Physicochemical characteristics. For compounds with limited data, we conduct extensive literature reviews and apply read-across methodologies.',
        },
      },
      {
        '@type': 'Question',
        name: 'How do you ensure TRA reports meet different regulatory expectations?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Our reports include: 1) Methodology alignment statements, 2) Regional requirement cross-references, 3) Multiple scenario analyses (EMA vs FDA approaches), and 4) Customizable appendices for specific markets. We maintain current regulatory intelligence through our global network of toxicology experts.',
        },
      },
      {
        '@type': 'Question',
        name: 'What makes your cleaning limit justifications inspection-ready?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We provide: 1) Transparent uncertainty factor application, 2) Multiple calculation methods (PDE, therapeutic dose, LD50-based), 3) Worst-case scenario analysis, 4) Equipment grouping rationale, and 5) Ready responses to common inspector questions. All assumptions are scientifically justified and referenced.',
        },
      },
      {
        '@type': 'Question',
        name: 'Can you support TRA updates when new toxicological data emerges?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Yes, we offer: 1) Annual toxicology monitoring services, 2) Expedited report revisions, 3) Change impact assessments, and 4) Version control documentation. Our enterprise clients receive automatic literature surveillance for their compound portfolios.',
        },
      },
      {
        '@type': 'Question',
        name: 'How do you handle highly potent compounds in TRA assessments?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'For HPAPIs, we: 1) Apply additional safety factors, 2) Consider occupational exposure limits, 3) Evaluate genotoxic potential, 4) Assess compound-specific detection challenges, and 5) Provide enhanced cleaning validation recommendations. Our team has specialized experience with oncology compounds and cytotoxic agents.',
        },
      },
      {
        '@type': 'Question',
        name: 'What ongoing support do you provide after delivering TRA reports?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We offer: 1) 30-day complimentary consultation, 2) Audit/inspection support, 3) Staff training sessions, 4) Regulatory update alerts, and 5) Discounted reassessment services. Premium support packages include dedicated toxicologist access and document control services.',
        },
      },
      {
        '@type': 'Question',
        name: 'What is a Toxicological Risk Assessment (TRA) in pharmaceuticals?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'A Toxicological Risk Assessment (TRA) evaluates the safety risks of pharmaceutical compounds, establishing health-based exposure limits (HBELs) and providing justifications for cleaning validation and contamination control to ensure product safety and regulatory compliance.',
        },
      },
      {
        '@type': 'Question',
        name: 'How does Indivirtus ensure TRA reports are regulatory compliant?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Our TRA reports align with EMA, FDA, WHO, PIC/S, and ICH guidelines. They undergo dual review by certified toxicologists and include regulatory alignment statements to ensure audit readiness and global market compliance.',
        },
      },
      {
        '@type': 'Question',
        name: 'What deliverables are included in the TRA and HBEL documentation service?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Deliverables include a comprehensive TRA report with executive summary, detailed toxicological monograph, HBEL/PDE calculations, cleaning validation limit rationale, cross-contamination risk assessment matrix, PQR support documentation, regulatory compliance gap analysis, inspection-ready presentation package, and training materials.',
        },
      },
      {
        '@type': 'Question',
        name: 'How long does it take to prepare a TRA report?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'The timeline varies based on compound complexity, but we typically deliver TRA reports within 7-14 business days. Expedited options are available for urgent requirements.',
        },
      },
      {
        '@type': 'Question',
        name: 'Why is a dual review by certified toxicologists important for TRA reports?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'A dual review ensures scientific accuracy and regulatory defensibility. Our certified toxicologists validate all data and justifications, providing confidence in the report’s reliability for regulatory submissions.',
        },
      },
    ],
  },
  meta: {
    title: 'Expert Toxicological Risk Assessment (TRA) Reports | HBEL & Cleaning Validation - Indivirtus',
    description:
      'Regulatory-compliant TRA reports with HBEL determination, cleaning validation justification, and cross-contamination control strategies for global pharmaceutical compliance.',
    keywords: [
      'TRA report service',
      'toxicological risk assessment',
      'HBEL determination',
      'cleaning validation justification',
      'PQR documentation support',
      'pharma cross-contamination control',
      'EMA FDA compliant TRA',
      'toxicology monograph preparation',
      'inspection-ready risk assessment',
      'GMP toxicology documentation',
    ],
    ogTags: {
      type: 'service',
      image: serviceImage.src,
      url: `https://www.indivirtus.com${link}`,
      site_name: 'Indivirtus Regulatory Services',
      published_time: '2023-05-10T00:00:00+05:30',
      modified_time: '2023-08-15T00:00:00+05:30',
    },
    twitterCard: {
      card: 'summary_large_image',
      title: 'Professional TRA Report Services | Indivirtus',
      description: 'Scientifically validated TRA reports with regulatory compliance assurance.',
      image: serviceImage.src,
      site: '@indivirtus',
      creator: '@indivirtus_tox',
    },
    canonicalUrl: `https://www.indivirtus.com${link}`,
    robotsMeta: {
      index: true,
      follow: true,
      nocache: false,
      googlebot: 'index, follow',
    },
    additionalMeta: {
      viewport: 'width=device-width, initial-scale=1.0',
      themeColor: '#0066cc',
      author: 'Indivirtus Toxicology Team',
    },
  },
  assessmentTypes: [
    'Standard TRA Report',
    'HPAPI Risk Assessment',
    'Cleaning Validation Justification',
    'PQR Support Package',
    'Cross-Contamination Strategy',
    'Regulatory Gap Analysis',
  ],
  serviceTiers: [
    {
      name: 'Basic TRA Package',
      features: [
        'Single compound assessment',
        'HBEL/PDE calculation',
        'Basic cleaning limit justification',
        'Regulatory compliance check',
      ],
      deliveryTime: '5-7 business days',
    },
    {
      name: 'Comprehensive TRA',
      features: [
        'Multi-product evaluation',
        'Detailed toxicological monograph',
        'Cleaning validation strategy',
        'Cross-contamination analysis',
        'Inspection-ready formatting',
      ],
      deliveryTime: '7-10 business days',
    },
    {
      name: 'Enterprise Solution',
      features: [
        'Facility-wide assessment',
        'Regulatory intelligence monitoring',
        'Dedicated toxicologist support',
        'Annual review and updates',
        'Inspection response package',
      ],
      deliveryTime: 'Custom timeline',
    },
  ],
};
